Get startedLog in
    Picture of POINT Biopharma Global logo

    PNT — POINT Biopharma Global News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    All News

    Brief: First European Union Patient Dosed with 177Lu-PNT2002 In Phase 3 SPLASH Trial

    Picture of POINT Biopharma Global logoPOINT Biopharma Global
    26/04/2022 13:40
    April 26 (Reuters) - POINT Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA GLOBAL INC - FIRST EUROPEAN UNION PATIENT
DOSED
WITH 177LU-PNT2002 IN PHASE 3 SPLASH TRIAL
    * POINT BIOPHARMA GLOBAL INC - REMAIN ON TRACK TO COMPLETE
RECRUITMENT BY END OF THIS YEAR

Source text for Eikon:  ID:nGNX68VqKs 
Further company coverage:  PNT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on POINT Biopharma Global

    See all news